1. Home
  2. AXDX vs NCSM Comparison

AXDX vs NCSM Comparison

Compare AXDX & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXDX
  • NCSM
  • Stock Information
  • Founded
  • AXDX 1982
  • NCSM 2006
  • Country
  • AXDX United States
  • NCSM United States
  • Employees
  • AXDX N/A
  • NCSM N/A
  • Industry
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • NCSM Oilfield Services/Equipment
  • Sector
  • AXDX Industrials
  • NCSM Energy
  • Exchange
  • AXDX Nasdaq
  • NCSM Nasdaq
  • Market Cap
  • AXDX 44.5M
  • NCSM 51.9M
  • IPO Year
  • AXDX 1996
  • NCSM 2017
  • Fundamental
  • Price
  • AXDX $1.85
  • NCSM $22.94
  • Analyst Decision
  • AXDX Hold
  • NCSM
  • Analyst Count
  • AXDX 1
  • NCSM 0
  • Target Price
  • AXDX $1.00
  • NCSM N/A
  • AVG Volume (30 Days)
  • AXDX 61.8K
  • NCSM 5.0K
  • Earning Date
  • AXDX 11-07-2024
  • NCSM 10-30-2024
  • Dividend Yield
  • AXDX N/A
  • NCSM N/A
  • EPS Growth
  • AXDX N/A
  • NCSM N/A
  • EPS
  • AXDX N/A
  • NCSM 16.77
  • Revenue
  • AXDX $11,909,000.00
  • NCSM $152,801,000.00
  • Revenue This Year
  • AXDX $1.42
  • NCSM $13.26
  • Revenue Next Year
  • AXDX $4.09
  • NCSM $6.32
  • P/E Ratio
  • AXDX N/A
  • NCSM $1.37
  • Revenue Growth
  • AXDX N/A
  • NCSM 3.66
  • 52 Week Low
  • AXDX $0.73
  • NCSM $12.16
  • 52 Week High
  • AXDX $5.52
  • NCSM $23.45
  • Technical
  • Relative Strength Index (RSI)
  • AXDX 48.99
  • NCSM 72.79
  • Support Level
  • AXDX $1.77
  • NCSM $22.21
  • Resistance Level
  • AXDX $2.04
  • NCSM $23.45
  • Average True Range (ATR)
  • AXDX 0.11
  • NCSM 0.87
  • MACD
  • AXDX -0.01
  • NCSM 0.39
  • Stochastic Oscillator
  • AXDX 29.63
  • NCSM 91.71

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.

Share on Social Networks: